Comparative Pharmacokinetics of Two Fast-Dissolving Oral Ibuprofen Formulations and a Regular-Release Ibuprofen Tablet in Healthy Volunteers

Authors: Schettler T.1; Paris S.1; Pellett M.2; Kidner S.2; Wilkinson D.2

Source: Clinical Drug Investigation, Volume 21, Number 1, 2001 , pp. 73-78(6)

Publisher: Adis International

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content

Abstract:

Objective: Spalt-Liqua is a new soft gelatin capsule containing 200mg of totally dissolved ibuprofen as the active ingredient. The primary objective of the study was to assess bioequivalence between the new ibuprofen formulation and the standard 200mg sugar-coated tablets. The secondary objective was to assess bioequivalence between the new formulation and 200mg tablets of a fast-dissolving ibuprofen lysinate formulation.

Design and Study Participants: A single oral dose of ibuprofen 400mg (two of each type of capsule or tablet) was administered to 26 healthy male volunteers in a nonblind, randomised, three-way crossover study with a 6-day washout interval between each drug administration period.

Main Outcome Measures and Results: For the soft gelatin capsules, maximum concentration (C) was significantly greater and time to reach maximum concentration (t) was significantly shorter in comparison with the reference tablet formulation, and therefore bioequivalence for these parameters could not be confirmed. However, the shorter absorption time and higher peak plasma concentration did not affect the extent of absorption of the soft gelatin capsule. In contrast to this result, the pharmacokinetic profile of the soft gelatin capsules was very similar to that of the fast-dissolving ibuprofen lysinate tablets. The 90% confidence intervals for logarithmically transformed C and areas under the drug concentration-time curve from zero to the time of the last measurable concentration (AUC) and to infinity (AUC) were within the required bioequivalence range. The three formulations were well tolerated and no clinically significant adverse events were observed.

Conclusions: In accordance with previous results, this study confirmed the pharmacokinetic differences between a standard ibuprofen tablet formulation and fast-dissolving formulations.

Keywords: Ibuprofen, pharmacokinetics; Nonsteroidal antiinflammatories, pharmacokinetics

Language: English

Document Type: Original article

Affiliations: 1: Whitehall-Much GmbH, Münster, Germany 2: Whitehall International, Havant, Hants, England *

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$62.95 plus tax      Refund Policy

 

OR

Back to top

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A